Jump to content

In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19


Recommended Posts

Posted

In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19

By Kate Kelland and Paul Sandle

 

2021-02-17T150626Z_1_LYNXMPEH1G18W_RTROPTP_4_HEALTH-CORONAVIRUS-BRITAIN-CHALLENGE.JPG

FILE PHOTO: Deputy charge nurse Katie McIntosh administers the first of two Pfizer/BioNTech COVID-19 vaccine jabs, to Vivien McKay Clinical Nurse Manager at the Western General Hospital, on the first day of the largest immunisation programme in the British history, in Edinburgh, Scotland Britain December 8, 2020. Andrew Milligan/Pool via REUTERS

 

LONDON (Reuters) - Britain became the first country in the world on Wednesday to give the go-ahead for human challenge trials in which volunteers will be deliberately exposed to COVID-19 to advance research into the disease caused by the novel coronavirus.

 

The trial, due to start within a month, will see up to 90 healthy volunteers aged between 18 and 30 exposed to the smallest amount of the virus needed to cause infection, scientists behind the plans told reporters at a news briefing.

 

Volunteers will be screened for possible health risks before being allowed to take part, and kept in quarantine for close monitoring by medical staff for at least 14 days in a specialist unit at London's Royal Free Hospital.

 

"The absolute priority, of course, is the safety of volunteers," said Peter Openshaw, a professor of experimental medicine at Imperial College London, which is co-leading the project with the UK government's vaccines task force and the clinical company  hVIVO. "None of us wants to do this if there is any appreciable risk."

 

Scientists have used human challenge trials for decades to learn more about diseases such as malaria, flu, typhoid and cholera, and to develop treatments and vaccines against them.

 

Participants in the UK COVID-19 challenge trial will be allowed to go home after the initial 14 days only if "extensive testing" shows they are not infectious, said Imperial's Chris Chiu, the trial's chief investigator.

 

Campaigners from a group called 1Day Sooner, which has been lobbying governments around the world to conduct human challenge trials with the novel coronavirus, welcomed the UK's move, saying it would accelerate research into COVID-19 vaccines and treatments.

 

Alistair Fraser-Urquhart, a campaigner who said he'd like to participate in the study, said in a statement he had "spent a long time dwelling" on the risks, but was "ready to take them on for the benefit of others".

 

Chiu said the aim of this initial work is "to understand how the virus infects people and how it passes so successfully between us."

 

Further trials using the challenge models could then be conducted in the months and years ahead to establish which vaccines and treatments work best, he said.

 

Volunteers will get compensation payments of around £88 ($122) per day for the duration of the study, which will also involve follow-up monitoring for a year, Chiu's team said, and the studies will be conducted in a safe and controlled environment and will minimise any risk.

 

To make the trial as safe as possible, the version of the SARS-CoV-2 virus that has been circulating in England since March 2020 will be used, rather than one of the new variants, they said.

 

Lawrence Young, a virologist and professor of molecular oncology at Warwick University who is not involved with the study, said it - like similar ones using other pathogens before it - should provide crucial insights into the SARS-CoV-2 virus.

 

"Human challenge trials ... have been used to study infections ... ranging from the common cold viruses to malaria," he said. "Such controlled studies provide insights into the host-pathogen interaction, facilitate the identification of correlates of protection and accelerate the development of vaccines and novel therapies."

 

(Editing by Bernadette Baum)

 

reuters_logo.jpg

-- © Copyright Reuters 2021-02-18
 
Posted

They were supposed to be doing this last summer, I read a news story about the recruitment, they were paying people.

 

Perhaps that's the difference between direct government studies and more public ones.

 

I'll bet many 100's have already been paid to be infected in 'hushed' up government research over there already, nothing is left to chance.

 

Things like this can be done inside the armed forces with volunteers who are enticed.

 

  • Sad 1
Posted
18 hours ago, webfact said:

In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19

tell you what, guinea pigs can't believe their luck

Posted
18 hours ago, webfact said:

Volunteers will get compensation payments of around £88 ($122) per day for the duration of the study, which will also involve follow-up monitoring for a year, Chiu's team said, and the studies will be conducted in a safe and controlled environment and will minimise any risk.

Volunteers accept all the risk for peanuts to be human guinea pigs for pharmaceutical companies which will make billions from their vaccines if they hit the markets.

The human guinea pigs should be making closer to $1000/day.  So as usual, corporations will find the most financially desperate to experiment on.  Informed consent?  Uh-huh.  Ethically?  This just sucks. 

  • Sad 1
  • Thanks 1
Posted
22 minutes ago, connda said:

Volunteers accept all the risk for peanuts to be human guinea pigs for pharmaceutical companies which will make billions from their vaccines if they hit the markets.

The human guinea pigs should be making closer to $1000/day.  So as usual, corporations will find the most financially desperate to experiment on.  Informed consent?  Uh-huh.  Ethically?  This just sucks. 

I suspect we would have to see what's in the fine print.  They will be following up for year.  If they are getting paid for the duration, that's a pretty good deal.   

 

The question is how much compensation and help will they get if they get sick and have complications that affect their ability to work?   

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...